Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5734542 | Surgery | 2017 | 7 Pages |
Abstract
CYP4B1 is silenced in both benign and malignant adrenocortical tumors and may contribute to tumorigenesis and chemoresistance. Sensitization of adrenocortical carcinoma cells engineered to overexpress CYP4B1 further supports this notion.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Timothy D. MD, Reju PhD, Tobias MD, PhD,